Trials / Completed
CompletedNCT01806311
Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg
An Open-label, Multiple-dose, Two-arm, One-sequence, Crossover Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of amlodipine10mg and candesartan32mg in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- HanAll BioPharma Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Clinical trial to evalate the pharmacokinetic interactions and safety between single dose of amlodipine10mg and candesartan32mg and combiation dose amlodipine10mg with candesartan32mg in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Candesartan32mg | |
| DRUG | Amlodipine10mg |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2013-03-07
- Last updated
- 2025-04-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01806311. Inclusion in this directory is not an endorsement.